Skip to content
On May 23, the House Committee on Oversight and Accountability sought to answer this question: are PBMs (pharmacy benefit managers) working in the interest […]
Are PBMs working in the interest of health care – or themselves? Read More »
The Biotechnology Innovation Organization (BIO), along with its members, sent a letter to Congressional leadership earlier this month urging for legislative action to be
Why Congress must repeal the R&D amortization provision Read More »
Pharmacy benefit managers (PBMs) and hospitals using the 340B program were in the crosshairs on May 17 as the House Energy & Commerce Health
E&C Health Subcommittee advances bills to bring transparency to PBMs and 340B Read More »
Inventions like AI-developed drugs belong to the human inventor, says the Biotechnology Innovation Organization (BIO) in comments to the U.S. Patent and Trademark Office
Who owns drugs developed with AI? Read More »
U.S. Senators have been busy this week understanding and pushing forward PBM reform. On May 10, the Senate Health, Education, Labor, and Pensions (HELP) Committee
Senate HELP Committee advances PBM reform Read More »
“What scientists are telling us is that there is a reasonable chance that—God forbid—a pandemic is deadly as COVID-19 could occur in 10 years,”
What they said at the Senate HELP hearing on PAHPA reauthorization Read More »
Exciting new therapies promise to transform medicine. But ensuring patients can access these complex treatments may require innovative payment models, says a study published
Transformative therapies need new payment models, study finds Read More »
The Senate Health, Education, Labor, and Pension (HELP) Committee on May 2 discussed Senate Bill 1339, “The Pharmacy Benefit Manager Reform Act,” and three
Vote on Pharmacy Benefit Manager Reform Act delayed until May 11 Read More »
Ordinary market mechanisms are inadequate against the emerging public health threat of antimicrobial resistance (AMR), lawmakers and experts agreed at the April 28 hearing
Hearing on public health threat from AMR puts spotlight on PASTEUR Act Read More »
On April 27, a group of bipartisan U.S. Senators and U.S. Representatives reintroduced the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act. The
PASTEUR Act reintroduced in House, Senate Read More »
